- Home
- COVID-19
-
- FOCUS: A study to test a new treatment for dry AMD
- Investigation of protein defects in retinal degenerations
- MACTEL
- MACTEL PHASE 3- NTMT-03
- MERIT
- Natural History Of Choroideremia (Night Study)
- PressOp™
- Regenerate
- SANDMAN
- SCOPE
- SeaSTAR
- Somnus Sleep Wake Study
- STAR trial (phase 3 gene therapy)
- UK Inherited Retinal Disease Consortium (UKIRDC)
- XIRIUS – Phase I/II Study of Retinal Gene Therapy for X-linked Retinitis Pigmentosa
- Xolaris (X-linked RP observational study)
- Meet the team
- Contact us